Discover the risks of off-label antidepressant prescriptions like mirtazapine for chronic respiratory disease.
Vous n'êtes pas connecté
Highlights: Mirtazapine does not relieve breathlessness and may increase healthcare burden 19% of respiratory do
Discover the risks of off-label antidepressant prescriptions like mirtazapine for chronic respiratory disease.
The US Presidential Election 2024 brings two distinct healthcare visions from Kamala Harris and Donald Trump, reflecting broader ideological...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
A recent study by scientists at McGill University has raised concerns about the common use of anti-inflammatory drugs and steroids to relieve pain....
A recent study by scientists at McGill University has raised concerns about the common use of anti-inflammatory drugs and steroids to relieve pain....
Review highlights the potential health benefits of raw white garlic consumption, particularly in improving cardiometabolic biomarkers and reducing...
GSK announces positive data from a phase III study of Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).
GSK announces positive data from a phase III study of Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).
WEDNESDAY, Sept. 11, 2024 -- A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident...